Pharmacogenomic Discovery to Function and Mechanism: Breast Cancer as a Case Study

E-ISSN： 1532-6535|103|2|243-252

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.103, Iss.2, 2018-02, pp. : 243-252

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intracrine mechanism of estrogen synthesis in breast cancer

By Suzuki T. Moriya T. Ishida T. Ohuchi N. Sasano H.

Biomedicine and Pharmacotherapy, Vol. 57, Iss. 10, 2003-12 ,pp. : 460-462

Elsevier

Access to resources Recommend Favorite

Pharmacogenomic biomarkers for personalized cancer treatment

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 2, 2015-02 ,pp. : 201-217

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Case Study of the Utility of the HapMap Database for Pharmacogenomic Haplotype Analysis in the Taiwanese Population

By Lin Eugene Hwang Yuchi Tzeng Chi-Meng

Molecular Diagnosis & Therapy, Vol. 10, Iss. 6, 2006-01 ,pp. : 367-370

Adis International

Access to resources Recommend Favorite

Re: Self-Reported Sleep Duration, Sleep Quality, and Breast Cancer Risk in a Population-Based Case-Control Study

By Erren Thomas C.

American Journal of Epidemiology, Vol. 177, Iss. 9, 2013-05 ,pp. : 1020-1021

Oxford University Press

Access to resources Recommend Favorite

Breast Cancer Risk Factors among Ugandan Women at a Tertiary Hospital: A Case-Control Study

Oncology, Vol. 90, Iss. 6, 2016-04 ,pp. : 356-362

Karger

Access to resources Recommend Favorite